3-((1S,3S)-1-(4-fluorophenyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamido)propanoic acid

ID: ALA5204377

Chembl Id: CHEMBL5204377

PubChem CID: 168293694

Max Phase: Preclinical

Molecular Formula: C19H19FN2O5

Molecular Weight: 374.37

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CCNC(=O)[C@@H]1Cc2cc(O)c(O)cc2[C@H](c2ccc(F)cc2)N1

Standard InChI:  InChI=1S/C19H19FN2O5/c20-12-3-1-10(2-4-12)18-13-9-16(24)15(23)8-11(13)7-14(22-18)19(27)21-6-5-17(25)26/h1-4,8-9,14,18,22-24H,5-7H2,(H,21,27)(H,25,26)/t14-,18-/m0/s1

Standard InChI Key:  VXTOGCNEJGSQMZ-KSSFIOAISA-N

Alternative Forms

  1. Parent:

    ALA5204377

    ---

Associated Targets(Human)

TRPV1 Tclin Vanilloid receptor (8273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trpm8 Transient receptor potential cation channel subfamily M member 8 (889 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.37Molecular Weight (Monoisotopic): 374.1278AlogP: 1.43#Rotatable Bonds: 5
Polar Surface Area: 118.89Molecular Species: ACIDHBA: 5HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 3.58CX Basic pKa: 6.35CX LogP: -0.61CX LogD: -1.46
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: -0.06

References

1. Di Sarno V, Giovannelli P, Medina-Peris A, Ciaglia T, Di Donato M, Musella S, Lauro G, Vestuto V, Smaldone G, Di Matteo F, Bifulco G, Castoria G, Migliaccio A, Fernandez-Carvajal A, Campiglia P, Gomez-Monterrey I, Ostacolo C, Bertamino A..  (2022)  New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models.,  238  [PMID:35598411] [10.1016/j.ejmech.2022.114435]

Source